» Articles » PMID: 8759866

Control of AlgU, a Member of the Sigma E-like Family of Stress Sigma Factors, by the Negative Regulators MucA and MucB and Pseudomonas Aeruginosa Conversion to Mucoidy in Cystic Fibrosis

Overview
Journal J Bacteriol
Specialty Microbiology
Date 1996 Aug 1
PMID 8759866
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

The alternative sigma factor AlgU (Pseudomonas aeruginosa sigma E) is required for full resistance of P. aeruginosa to oxidative stress and extreme temperatures. AlgU also controls conversion of P. aeruginosa to the mucoid, alginate-overproducing phenotype associated with lethal infections in cystic fibrosis patients. Mutations that cause conversion to mucoidy in cystic fibrosis isolates occur frequently in mucA, the second gene within the algU mucABCD gene cluster. Here we analyze the biochemical basis of conversion to mucoidy. MucA was shown to act as an anti-sigma factor by binding to AlgU and inhibiting its activity. MucB, another negative regulator of AlgU, was localized in the periplasm. MucB exerts its function from this compartment, since deletion of the leader peptide and the cytoplasmic location of MucB abrogated its ability to inhibit mucoidy. These data support a model in which a multicomponent system, encompassing an anti-delta factor and elements in the periplasmic compartment, modulates activity of AlgU. Since factors controlling AlgU are conserved in other gram-negative bacteria, the processes controlling conversion to mucoidy in P. aeruginosa may be applicable to the regulation of AlgU (sigma E) equivalents in other organisms.

Citing Articles

and analyses of the role of the Prc protease in inducing mucoidy in .

Sommerfield A, Wang M, Mamana J, Darwin A J Bacteriol. 2024; 206(10):e0022224.

PMID: 39287400 PMC: 11500579. DOI: 10.1128/jb.00222-24.


tRNA modification profiling reveals epitranscriptome regulatory networks in .

Sun J, Wu J, Yuan Y, Fan L, Chua W, Ling Y bioRxiv. 2024; .

PMID: 39005467 PMC: 11245014. DOI: 10.1101/2024.07.01.601603.


Pseudomonas aeruginosa biofilm exopolysaccharides: assembly, function, and degradation.

Gheorghita A, Wozniak D, Parsek M, Howell P FEMS Microbiol Rev. 2023; 47(6).

PMID: 37884397 PMC: 10644985. DOI: 10.1093/femsre/fuad060.


State of Innovation in Alginate-Based Materials.

Adamiak K, Sionkowska A Mar Drugs. 2023; 21(6).

PMID: 37367678 PMC: 10302983. DOI: 10.3390/md21060353.


A truncated mutation of MucA in from a bronchiectasis patient affects T3SS expression and inflammasome activation.

Liu Y, Du L, Zhu Y, Liu X, Zhou N, Li C Acta Biochim Biophys Sin (Shanghai). 2023; 54(11):1740-1747.

PMID: 36604139 PMC: 9828237. DOI: 10.3724/abbs.2022169.


References
1.
Goldberg J, Gorman W, Flynn J, Ohman D . A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J Bacteriol. 1993; 175(5):1303-8. PMC: 193215. DOI: 10.1128/jb.175.5.1303-1308.1993. View

2.
Duncan L, Losick R . SpoIIAB is an anti-sigma factor that binds to and inhibits transcription by regulatory protein sigma F from Bacillus subtilis. Proc Natl Acad Sci U S A. 1993; 90(6):2325-9. PMC: 46079. DOI: 10.1073/pnas.90.6.2325. View

3.
Pugsley A . The complete general secretory pathway in gram-negative bacteria. Microbiol Rev. 1993; 57(1):50-108. PMC: 372901. DOI: 10.1128/mr.57.1.50-108.1993. View

4.
Martin D, Schurr M, Mudd M, Govan J, Holloway B, Deretic V . Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993; 90(18):8377-81. PMC: 47359. DOI: 10.1073/pnas.90.18.8377. View

5.
Martin D, Schurr M, Mudd M, Deretic V . Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol Microbiol. 1993; 9(3):497-506. DOI: 10.1111/j.1365-2958.1993.tb01711.x. View